206 related articles for article (PubMed ID: 20638026)
1. Management of end-stage liver disease in chronic hepatitis B.
Tan HH; Martin P
Clin Liver Dis; 2010 Aug; 14(3):477-93. PubMed ID: 20638026
[TBL] [Abstract][Full Text] [Related]
2. Antiviral therapy for chronic hepatitis B.
Jafri SM; Lok AS
Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
[TBL] [Abstract][Full Text] [Related]
3. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
Triolo M; Della Corte C; Colombo M
Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
[TBL] [Abstract][Full Text] [Related]
4. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
Dusheiko G
Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
[TBL] [Abstract][Full Text] [Related]
5. [Chronic hepatitis B].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
[No Abstract] [Full Text] [Related]
6. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
Liaw YF
Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
[TBL] [Abstract][Full Text] [Related]
7. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.
Papatheodoridis GV; Dimou E; Dimakopoulos K; Manolakopoulos S; Rapti I; Kitis G; Tzourmakliotis D; Manesis E; Hadziyannis SJ
Hepatology; 2005 Jul; 42(1):121-9. PubMed ID: 15962291
[TBL] [Abstract][Full Text] [Related]
8. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis B: Evolution over two decades.
Yuen MF; Lai CL
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
[TBL] [Abstract][Full Text] [Related]
10. Natural history of chronic hepatitis B virus infection.
Busch K; Thimme R
Med Microbiol Immunol; 2015 Feb; 204(1):5-10. PubMed ID: 25540037
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis B: who to treat and which choice of treatment?
Di Marco V; Craxì A
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
[TBL] [Abstract][Full Text] [Related]
12. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
Warner N; Locarnini S
Antivir Ther; 2009; 14(2):139-42. PubMed ID: 19430088
[No Abstract] [Full Text] [Related]
13. Current treatment and future directions in the management of chronic hepatitis B viral infection.
Gish RG
Clin Liver Dis; 2005 Nov; 9(4):541-65, v. PubMed ID: 16207563
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.
Brown A; Goodman Z
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):187-98. PubMed ID: 22375524
[TBL] [Abstract][Full Text] [Related]
15. Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.
Chien RN; Liaw YF
Best Pract Res Clin Gastroenterol; 2008; 22(6):1081-92. PubMed ID: 19187868
[TBL] [Abstract][Full Text] [Related]
16. [Advances in the diagnosis and treatment of the infection by the hepatitis B virus].
Núñez M; García-Samaniego J; Soriano V
Enferm Infecc Microbiol Clin; 2004 Nov; 22(9):539-49. PubMed ID: 15511395
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection--natural history and clinical consequences.
Ganem D; Prince AM
N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
[No Abstract] [Full Text] [Related]
18. Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.
Buster EH; Hansen BE; Buti M; Delwaide J; Niederau C; Michielsen PP; Flisiak R; Zondervan PE; Schalm SW; Janssen HL;
Hepatology; 2007 Aug; 46(2):388-94. PubMed ID: 17604363
[TBL] [Abstract][Full Text] [Related]
19. [HCV-HBV infection].
Imamura M; Chayama K
Nihon Rinsho; 2006 Jul; 64(7):1310-3. PubMed ID: 16838649
[TBL] [Abstract][Full Text] [Related]
20. Treatment of HBV-related cirrhosis.
Vallet-Pichard A; Mallet V; Costentin CE; Pol S
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
